Showing posts with label PDD-NOS. Show all posts
Showing posts with label PDD-NOS. Show all posts

Testosterone Levels Linked To Autistic Traits

Exposure to high levels of testosterone in the womb is related to the development of autistic traits.

This is the conclusion of groundbreaking research published in the British Journal of Psychology on 12th January 2009, which found that levels of testosterone in amniotic fluid were linked to children's autistic traits up to ten years later.

Psychologists Dr Bonnie Auyeung, Professor Simon Baron-Cohen and their team at the Autism Research Centre at the University of Cambridge measured the levels of foetal testosterone in the amniotic fluid of 235 women who underwent amniocentesis during pregnancy.

Years later these mothers completed questionnaires that measured their children's autistic traits. By this time, the 118 boys and 117 girls were aged between 6 and 10. High levels of foetal testosterone were found to be associated with high scores on two separate measures of autistic traits (the Child Autism Spectrum Quotient (AQ-Child) and the Childhood Autistic Spectrum Test (CAST)) for both boys and girls.

High scores on these measures of autistic traits reflected poorer social skills, imagination and mind reading but good attention to, and memory for detail. The team followed the children from before birth during the unique longitudinal project, which was funded by the Medical Research Council (UK) and the Boston-based Nancy Lurie Marks Family Foundation.

This research goes further than previous studies which have found that higher levels of foetal testosterone are associated with less eye contact at children's first birthday, slower language development at their second birthday, more peer difficulties at their fourth birthday, and more difficulties with empathy at their sixth birthday.

What is novel in this new study is that as it also links higher foetal testosterone to autistic traits such as excellent attention to detail, and a love of repetition, as well as social and communication difficulties.

Professor Baron-Cohen said: "The study highlights for the first time the association between foetal testosterone and autistic traits, and indicates that foetal testosterone not only masculinises the body, it masculinises the mind and therefore the brain. "We all have some autistic traits - these are a spectrum or a dimension of individual differences, like height. It is important to note that this research does not demonstrate that elevated foetal testosterone is associated with a clinical diagnosis of autism or Asperger Syndrome; to do that would need a sample size of thousands, not hundreds."

"Our ongoing collaboration with the Biobank in Denmark will enable us to test that link in the future. Dr Auyeung added: "Since the male foetus produces on average twice as much testosterone as the female foetus, the present research may be relevant to the theory that autistic spectrum conditions autism is reflect an 'extreme male brain' - that autism is an extreme manifestation in terms of the structure and function of the male brain. This theory may also explain the higher incidence of these conditions in boys than in girls." Notes The British Journal of Psychology Part 1 2009 also contains a commentary on this paper by Dr Ami Klin of Yale University School of Medicine.


The Autism Research Centre at Cambridge University comprises a group of scientists and clinicians conducting research into the psychology and biomedical aspects of autism and Asperger Syndrome, and pioneers the development and evaluation of special educational methods.

CARD Winter 08 Newsletter - Hot off the Press!

To read the latest autism news around the nation and inside of the Center for Autism and Related Disorders, Inc - please click here.

The CARD Position on Biomedical Treatment for Autism

The CARD Position on Biomedical Treatments for Autism, January 19, 2006

Autism is currently among the most controversial issues in American public health. Presumably because of the mysterious nature of the disorder, autism continues to be the focus of countless “fad treatments,” the vast majority of which either lack scientific support or have been scientifically disproved, outright (e.g., facilitated communication, see Jacobson, Mulick, & Schwartz, 1995). Several independent review sources have consistently found that early intensive applied behavior analytic intervention (ABA) continues to be the only treatment for autism which is backed by substantial scientific evidence (NYSDH, 1999; Satcher, 1999). The effectiveness of ABA has been replicated yet again in two recent outcome studies (Howard, Sparkman, Cohen, Green, & Stanislaw, 2005; Sallows & Graupner, 2005).

A substantial percentage of children with autism currently receive “biomedical” treatments, despite a current lack of evidence to support or refute most of them. In a recent survey of parents of children with autism (Green, et al., 2005), 27% of parents reported that their children with autism currently receive treatment in the form of special diets and 43% reported using vitamin supplements.

CARD’s position on the use of biomedical treatments in clinical practice is centered around three basic points: 1) many parents of children with autism believe that various biomedical treatments have been responsible for substantial improvement in their children, 2) very little research has been conducted on the effects of biomedical treatments for autism, and 3) parents must ultimately make the decision as to which treatments are appropriate for their children, regardless of diagnosis or disorder.

CARD’s position on research on biomedical treatments and on the collaboration of behavior analysts with clinicians and researchers from other disciplines is based on the points elaborated above. At least two factors contribute to what we perceive as a grievous need for sound empirical research on the effects of biomedical treatments for autism. First, as the Green, et al., (2005) study demonstrates, biomedical treatments are being implemented on a widespread basis. This fact alone is more than ample justification for conducting research on their safety and effectiveness. Such widespread use must be tempered with sound research. Second, many parents honestly believe that their children have significantly benefited from biomedical treatments. As clinicians and applied scientists, we have an ethical responsibility to take the concerns and beliefs of our clients seriously. To dismiss the convictions of our clients would be tantamount to disrespect for those who are mostly closely affected by autism. At the same time, ample research has demonstrated that clients can be made to believe that an intervention is or is not effective, regardless of the actual effects produced, and therefore opinion alone (be it that of a client or a scientist) is never to be accepted or rejected outright. Sound empirical treatment research is the only path toward addressing such concerns in a sufficient manner.

Throughout the history of science, particular schools of thought and areas of research have risen and fallen amidst ubiquitous controversy. Ultimately, controversy may have very little effect on which approaches to a problem are borne out. When a useful solution to a problem is discovered, and the results are replicated many times over, little is left to controversy. The use of ABA for children with autism was once highly controversial but the unrelenting work of parents and the repeated and consistent replication of beneficial results in the scientific literature has moved the field of ABA closer to the mainstream. Most biomedical treatments for autism have not yet been subjected to repeated, rigorous outcome research. Thus conclusions regarding their effectiveness (either for or against) cannot be made.

The best safeguard against controversy in the evaluation of scientific issues may be skepticism. Skepticism does not refer to disbelief. It refers to the practice of withholding judgment on a given topic until such time as sufficient evidence warrants judgment one way or the other (Shermer, 2002). In the absence of conclusive evidence, then, one might be advised to be skeptical of the view that an intervention works, as well as to be skeptical of the view that it does not. It is CARD’s position that conclusive evidence for or against the effectiveness of most biomedical treatments for autism does not at this time exist. Hence the urgent need for empirical investigation and the futility of blind acceptance or denial of the validity of the biomedical treatment of autism.

A common feature of any controversy is polarization. A casual review of the major clinical, research, and advocacy factions within the field of autism today reveals that most parties ardently maintain that biomedical treatments are either extremely effective or a total sham. Many who advocate for biomedical treatments appear to believe that all biomedical treatments are equally effective and all are virtual cures for autism. Many who reject the utility of biomedical treatments, on the other hand, do so across the entire range of treatments, without regard to the particular case for or against the many divergent treatments which fall under the biomedical umbrella. Particularly given the still largely unknown etiology of autism, either position appears premature at the current time. Autism is a spectrum disorder which is comprised of millions of individuals who present with widely divergent characteristics. It is not yet even known whether all cases of autism share a common etiology. Given the widely divergent manifestations of the disorder, if any biomedical treatments are proven to be effective in the future, it seems unlikely that any particular one will prove equally effective for all persons with autism. Even less likely is the notion that all biomedical treatments will be equally effective or ineffective, if the large variability within autism is ignored.

Perhaps most disturbing is the notion that it is not possible to reliably evaluate the separate and combined effects of ABA and biomedical treatments for autism. This perspective is based on a fundamental misunderstanding of the nature of experimental scientific investigation. Virtually all disciplines of experimental science agree that experimentation consists of altering one variable at a time and observing the effects that the alteration produces on another variable. Sound experimentation depends on manipulating one variable at a time while simultaneously controlling for the influence of extraneous variables. To the extent that this is done (regardless of the particular scientific field or research topic), inferences can be made about the effects of one variable on another. There is nothing peculiar about autism, ABA, or biomedical treatments which preclude this sort of experimentation. It is common for clinicians (behavioral, medical, or other) to manipulate multiple variables simultaneously in order to bring about optimal treatment outcome and any time this is done it is likely to preclude precise analysis of which variables were responsible for improvement. In order to produce sound research on the separate and combined effects (if any) of each approach, experiments must hold one variable constant while manipulating another. This approach to autism research is largely untouched within the ABA and biomedical communities, but this fact does not preclude such research from being developed, and indeed it is currently under way at several research sites.

Toward this end, CARD is currently collaborating with medical doctors to conduct sound research on biomedical treatments for autism. The focus of this effort is to identify which, if any, biomedical treatments result in which particular improvements for particular individuals with autism, given their unique biomedical and behavioral status. All research conducted is interdisciplinary in nature and all treatment studies evaluate multiple behavioral and biomedical measures. The goal is to establish a model for interdisciplinary collaboration between behavior analysts and medical doctors in researching treatment for individuals with autism. It is our hope that the research produced will forge a path toward addressing the debate regarding biomedical treatments for autism with sound scientific data, thereby displacing the current culture of hearsay and controversy.

In summary, the CARD position on the biomedical treatment of autism is not one of belief or disbelief, it is one of uncertainty. It is our hope that the coming decade will yield the evidence which is so desperately needed to transform the current debate about biomedical treatment from one based on subjective report to one which is grounded in sophisticated analysis of sound scientific data.

References


Green, V. A., Pituch, K. A., Itchon, J., Choi, A., O’Reilly, M., & Sigafoos, J. (in press). Internet survey of treatments used by parents of children with autism. Research in Developmental Disabilities.


Howard, J. S., Sparkman, C. R., Cohen, H. G., Green, G., & Stanislaw, H. (2005). A comparison of intensive behavior analytic and eclectic treatments for young children with autism. Research in Developmental Disabilities, 26, 359-383.

Jacobson, J., Mulick, J. A., & Schwartz, A. A. (1995). A history of facilitated communication: Science, pseudoscience, and antiscience science working group on facilitated communication. Americal Psychologist, 50, 750-765.

New York State Department of Health Early Intervention Program. Clinical Practice Guideline: Report of the Recommendations, Autism/Pervasive Developmental Disorders, Assessment and Intervention for Young Children. 1999. Publication #4215. Health Education Services, P.O. Box 7126, Albany, NY 12224.

Sallows, G. O., & Graupner, T. D. (2005). Intensive behavioral treatment for children with autism: Four-year outcome and predictors. American Journal on Mental Retardation, 110, 417-438.

Satcher, D. Mental health: A report of the surgeon general. U.S. Public Health Service. 1999. Bethesda, MD http://www.surgeongeneral.gov/library/mentalhealth/chapter3/sec6.html

Shermer, M. (2002). Why people believe weird things: Pseudoscience, superstition, and other confusions of our time. New York, NY: Henry Holt.

FOR MORE INFORMATION - VISIT: WWW.CENTERFORAUTISM.COM

Defining Autism


Defining Autism

Autism is a pervasive developmental disorder that is marked by the presence of impaired social interaction and communication and a restricted repertoire of activities and interests. The prevalence of autism has been estimated to affect as many as 1 in 150 children and is four times more common in boys than in girls.

Children with Autism show a great variance of symptoms ranging from severe impairment in the use of nonverbal behaviors that regulate social interaction to a failure to develop peer relationships appropriate to age.

Their impairment in communication is also marked and sustained and can affect both verbal and nonverbal skills. Autistic children may have a delay in or a total lack of spoken language. In children who do speak, there may be a delay in the ability to sustain a conversation with others, or a stereotypic and repetitive use of language.

Children with Autism may also show a lack of varied, spontaneous make believe play or social imitative play and often have restricted, repetitive and stereotyped patterns of activity.

Children with Autism may have a range of behavioral symptoms including hyperactivity, short attention span, impulsivity, aggressiveness, self-injurious behavior and temper tantrums. They may show unusual responses to sensory stimuli as observed by a lack of response to pain or a hypersensitivity to particular sounds. In addition, children with Autism often have unusual eating and sleeping habits and are described as being either agitated and irritable or aloof and detached.

Because autism is a severe, chronic developmental disorder that results in significant lifelong disability, the goal of treatment is to promote the child's social and language development and minimize behaviors that interfere with the child's functioning and learning. Intensive, sustained special education programs and behavior therapy early in life can increase the ability of the child with autism to acquire language and ability to learn.

Special education programs in highly structured environments appear to help the child acquire self-care, social, and job skills. Only in the past decade have studies shown positive outcomes for very young children with autism. Given the severity of the impairment, high intensity of service needs, and costs (both human and financial), there has been an ongoing search for effective treatment.

Diagnosis

The diagnosis of autism is a complex and often controversial issue. The most accepted standards for diagnosis come from the Diagnostic and Statistical Manual of Mental Disorders – Fourth Edition (DSM – IV), published by the American Psychiatric Association. The MADSEC report provides a useful, succinct description of the diagnosis and relevant factors comprising it.

Autism is included under DSM-IV’s pervasive developmental disorders. This is a category of disorders in which many basic areas of infant and child psychological development are affected at the same time, and to a severe degree.

Autistic disorder has three major hallmarks: qualitative impairment in social interaction, qualitative impairment in communication, and restricted, repetitive and stereotypical patterns of behavior, interests, and activities. Onset in delays is very early, prior to three years of age.

To meet DSM-IV diagnostic criteria for autism, children will display impairment in social interaction in at least two ways, impairment in communication in at least one way, and restricted, repetitive and stereotypical patterns of behavior, interests and activities in at least one way.

According to DSM-IV, impairment in social interaction is manifested in at least two of the following ways:

a) marked impairment in the use of multiple nonverbal behaviors such as eye-to-eye gaze, facial expression, body postures, and gestures to regulate social interaction;

b) failure to develop peer relationships appropriate to developmental level;

c) a lack of spontaneous seeking to share enjoyment, interests or achievement with other people;

d) lack of social or emotional reciprocity.

Impairment in communication is manifested by at least one of the following:

a) delay in, or total lack of, the development of spoken language, not accompanied by an attempt to compensate through alternative modes of communication;

b) in individuals with adequate speech, marked impairment in the ability to initiate or sustain conversation with others;

c) stereotyped and repetitive use of language or idiosyncratic language, and


d) lack of varied, spontaneous make-believe play or social imitative play appropriate to developmental level.

Restricted, repetitive and stereotyped patterns of behavior, interests and activities are manifested by at least one of the following:

  • encompassing preoccupation with one or more stereotyped and restricted patterns of interest that is abnormal either in intensity of focus;
  • apparently inflexible adherence to specific, non-functional routines or rituals;
  • stereotyped and repetitive motor mannerisms, such as hand or finger flapping, or complex whole body movements;
  • persistent preoccupation with parts of objects. (DSM-IV, 1994). (MADSEC, 2000, p. 7)

While the diagnostic criteria described above are widely applicable, it is important to note that very child with autism is unique, and there is no such thing as a “average” child with autism. Each child anifests unique strengths and skill deficits and it is important to keep in mind that treatment must therefore be oriented to an assessment of the unique needs of each individual person, not simply prescribed based on a diagnosis.

References

Maine Administrators of Services for Children with Disabilities (MADSEC) (2000). Report of the MADSEC Autism Task Force.

What is ABA?

What is Applied Behavior Analysis?

Behavior Analysis is the scientific study of behavior. Applied Behavior Analysis (ABA) is the application of the principles of learning and motivation from Behavior Analysis, and the procedures and technology derived from those principles, to the solution of problems of social significance. Many decades of research have validated treatments based on ABA.

The Report of the MADSEC Autism Task Force (2000) provides a succinct description, put together by an independent body of experts:

Over the past 30 years, several thousand published research studies have documented the effectiveness of ABA across a wide range of:

  • populations (children and adults with mental illness, developmental disabilities and learning disorders)
  • interventionists (parents, teachers and staff)
  • settings (schools, homes, institutions, group homes, hospitals and business offices), and
  • behaviors (language; social, academic, leisure and functional life skills; aggression, selfinjury, oppositional and stereotyped behaviors)

Applied behavior analysis is the process of systematically applying interventions based upon the principles of learning theory to improve socially significant behaviors to a meaningful degree, and to demonstrate that the interventions employed are responsible for the improvement in behavior (Baer, Wolf & Risley, 1968; Sulzer-Azaroff & Mayer, 1991).

“Socially significant behaviors” include reading, academics, social skills, communication, and adaptive living skills. Adaptive living skills include gross and fine motor skills, eating and food preparation, toileting, dressing, personal self-care, domestic skills, time and punctuality, money and value, home and community orientation, and work skills.

ABA methods are used to support persons with autism in at least six ways:

1. to increase behaviors (eg reinforcement procedures increase on-task behavior, or social interactions);

2. to teach new skills (eg, systematic instruction and reinforcement procedures teach functional life skills, communication skills, or social skills);

3. to maintain behaviors (eg, teaching self control and self-monitoring procedures to maintain and generalize job-related social skills);

4. to generalize or to transfer behavior from one situation or response to another (eg, from completing assignments in the resource room to performing as well in the mainstream classroom);

5. to restrict or narrow conditions under which interfering behaviors occur (eg, modifying the learning environment); and

6. to reduce interfering behaviors (eg, self injury or stereotypy).

ABA is an objective discipline. ABA focuses on the reliable measurement and objective
evaluation of observable behavior.

Reliable measurement requires that behaviors are defined objectively. Vague terms such as anger, depression, aggression or tantrums are redefined in observable and quantifiable terms, so their frequency, duration or other measurable properties can be directly recorded (Sulzer-Azaroff & Mayer, 1991). For example, a goal to reduce a child’s aggressive behavior might define “aggression” as: “attempts, episodes or occurrences (each separated by 10 seconds) of biting, scratching, pinching or pulling hair.” “Initiating social interaction with peers” might be defined as: “looking at classmate and verbalizing an appropriate greeting.”

ABA interventions require a demonstration of the events that are responsible for the occurrence,
or non-occurrence, of behavior. ABA uses methods of analysis that yield convincing, reproducible, and conceptually sensible demonstrations of how to accomplish specific behavior changes (Baer & Risley, 1987). Moreover, these behaviors are evaluated within relevant settings such as schools, homes and the community. The use of single case experimental design to evaluate the effectiveness of individualized interventions is an essential component of programs based upon ABA methodologies. This is a process that includes the following components:

a) selection of interfering behavior or behavioral skill deficit

b) identification of goals and objectives

c) establishment of a method of measuring target behaviors

d) evaluation of the current levels of performance (baseline)

e) design and implementation of the interventions that teach new skills and/or reduce interfering behaviors

f) continuous measurement of target behaviors to determine the effectiveness of the intervention, and

g) ongoing evaluation of the effectiveness of the intervention, with modifications made as necessary to maintain and/or increase both the effectiveness and the efficiency of the intervention. (MADSEC, 2000, p. 21-23)

As the MADSEC Report describes above, treatment approaches grounded in ABA are now considered to be at the forefront of therapeutic and educational interventions for children with autism. The large amount of scientific evidence supporting ABA treatments for children with autism have led a number of other independent bodies to endorse the effectiveness of ABA, including the U.S. Surgeon General, the New York State Department of Health, the National Academy of Sciences, and the American Academy of Pediatrics (see reference list below for sources).

Discrete Trial Training

Discrete trial training (DTT) is a particular ABA teaching strategy which enables the learner to acquire complex skills and behaviors by first mastering the subcomponents of the targeted skill. For example, if one wishes to teach a child to request a a desired interaction, as in "I want to play," one might first teach subcomponents of this skill, such as the individual sounds comprising each word of the request, or labeling enjoyable leisure activities as "play." By utilizing teaching techniques based on the principles of behavior analysis, the learner is gradually able to complete all subcomponent skills independently. Once the individual components are acquired, they are linked together to enable mastery of the targeted complex and functional skill. This methodology is highly effective in teaching basic communication, play, motor, and daily living skills.

Initially, ABA programs for children with Autism utilized only (DTT), and the curriculum focused on teaching basic skills as noted above. However, ABA programs, such as the program implemented at CARD, continue to evolve, placing greater emphasis on the generalization and spontaneity of skills learned. As patients progress and develop more complex social skills, the strict DTT approach gives way to treatments including other components.

Specifically, there are a number of weaknesses with DTT including the fact the DTT is primarily teacher initiated, that typically the reinforcers used to increase appropriate behavior are unrelated to the target response, and that rote responding can often occur. Moreover, deficits in areas such “emotional understanding,” “perspective taking” and other Executive Functions such as problem solving skills must also be addressed and the DTT approach is not the most efficient means to do so.

Although the DTT methodology is an integral part of ABA-based programs, other teaching strategies based on the principles of behavior analysis such as Natural Environment Training (NET) may be used to address these more complex skills. NET specifically addresses the above mentioned weaknesses of DTT in that all skills are taught in a more natural environment in a more “playful manner.” Moreover, the reinforcers used to increase appropriate responding are always directly related to the task (e.g., a child is taught to say the word for a preferred item such as a “car” and as a reinforcer is given access to the car contingent on making the correct response). NET is just one example of the different teaching strategies used in a comprehensive ABA-based program. Other approaches that are not typically included in strict DTT include errorless teaching procedures and Fluency-Based Instruction.

At CARD all appropriate teaching approaches based on the well grounded principles of applied behavior analysis are utilized.

References

Baer, D., Wolf, M., & Risley, R. (1968). Some current dimensions of applied behavior analysis. Journal of Applied Behavior Analysis, 1, 91 - 97.

Baer, D., Wolf, M., & Risley, R. (1987). Some still-current dimensions of applied behavior analysis. Journal of Applied Behavior Analysis, 20, 313 - 327.

Maine Administrators of Services for Children with Disabilities (MADSEC) (2000). Report of the MADSEC Autism Task Force.

Myers, S. M., & Plauché Johnson, C. (2007). Management of children with autism spectrum disorders. Pediatrics, 120, 1162-1182.

National Academy of Sciences (2001). Educating Children with Autism. Commission on Behavioral and Social Sciences and Education.

New York State Department of Health, Early Intervention Program (1999). Clinical Practice Guideline: Report of the Recommendations: Autism / Pervasive Developmental Disorders: Assessment and Intervention for Young Children (Age 0-3 years).

Sulzer-Azaroff, B. & Mayer, R. (1991). Behavior analysis for lasting change. Fort Worth, TX : Holt, Reinhart & Winston, Inc.

US Department of Health and Human Services (1999). Mental Health: A Report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services, National Institutes of Health, National Institute of Mental Health.

Autism Glossary - What it All Means

A
ABA: Applied Behavior Analysis

ABC: Autism Behavior Checklist - a diagnostic tool

ADA: Americans with Disabilities Act

ADD: Attention Deficit Disorder

ADHD: Attention Deficit Hyperactivity Disorder

ADI: Autism Diagnostic Interview - a diagnostic tool developed in London by the Medical Research Council

ADOS: Autism Diagnostic Observation Scale

AIT: Auditory Integration Training

AS: Asperger's Syndrome

ASA: Autism Society of America

ASD: Autism Spectrum Disorders


ASL: American Sign Language

C
CARS: Childhood Autism Rating Scale

CBCL: Achenbach Childhood Behavior Checklist - a diagnostic tool
CHAT: Checklist for Autism in Toddlers - a diagnostic tool

D
DAN Doctor: a physician who uses the DAN protocol to diagnose autism

DAN Protocol: an assessment protocol that examines the underlying disorders causing autism

DD: Developmental DisabilitiesDVD: Developmental Verbal Dyspraxia

E
EEG: ElectroencephalogramELAP: Early Learning Accomplishment Profile - an evaluation tool

F
FC: Facilitated CommunicationFCT: Facilitated Communication Training

G
GARS: Gilliam Autism Rating Scale

H
HFA: High-functioning Autistic

I
ICF: Intermediate Care Facility

IDEA: Individuals with Disabilities Act

IEP: Individualized Education Plan

IFSP: Individualized Family Service Plan

IHP: Individualized Habilitation Program

IPP: Individual Program Plan

L
LCSW: Licensed Clinical Social WorkerLRE: Least Restrictive Environment

M
MSDD: Multi-System Developmental Disorder

N
NT: Neurologically Typical or Neurotypical

NOS: Not Otherwise Specified

O
OCD: Obsessive Compulsive DisorderODD: Oppositional Defiant DisorderOT: Occupational Therapist

P
PDD: Pervasive Developmental Disorder

PDD NOS: Pervasive Developmental Disorder Not Otherwise Specified

PECS: Picture Exchange Communication System

PEP: Psycho-educational Profile

PEP-R: Psycho-educational Profile Revised

PRT: Pivotal Response Training

PT: Physical Therapy

S
SAS: Specialized Autism Services

SI: Sensory Integration

SIB: Self-Injurious Behavior

SIT: Sensory Integration Therapy

T
TEACCH: Treatment and Education of Autistic and Related Communication Handicapped Children

Dr. Doreen Granpeesheh on Dialogue with Doti and Dodge

Dialogue with Doti and Dodge is a PBS talk show, based in Orange, California. This show you are about to watch features Dr. Doreen Granpeesheh, one of the nation's leading autism researchers and psychologists and Nancy Alspaugh, executive director of Autism Care and Treatment. Watch the show now!

Early Intensive Behavioral Treatment Case Study

Early Intensive Behavioral Treatment
for a Toddler with Autism: Case Study of Outcome

By:
Mary Ann Cassell
L. Fernando Guerrero
Jonathan Tarbox
Rachel S. F. Tarbox
Doreen Granpeesheh
Center for Autism and Related Disorders (CARD)


This case study describes the course and outcome of EIBI for a toddler diagnosed with autism who achieved optimal outcomes. The participant in this case received approximately three years of EIBI, addressing complex social skills (e.g., perspective taking, reciprocal social interactions, etc.), and incorporating naturalistic teaching procedures in combination with discrete trial training.

At the conclusion of EIBI, he achieved scores in the normal range on assessments of IQ, language, and adaptive behavior. He is currently placed in a typical kindergarten, is earning average or better report cards with no concerns, and his kindergarten teacher is unaware that he ever had a diagnosis of autism.

View complete case study.

Dr. Doreen Granpeesheh Speaks in Florida

AUTISM EXPERT PRESENTS WHY BEHAVORIAL AND BIOMEDIAL INTERVENTIONS ARE CRITICAL TO GROWTH AND RECOVERY AT NATIONAL AUTISM CONFERENCE

Media Contact:
Daphne Plump November 03, 2008
Center for Autism and Related Disorders, Inc.
19019 Ventura Blvd, Ste 300, Tarzana, CA
(o) 818.345.2345 x 270 / (c) 661.478.6512

Ft. Lauderdale, Florida – Doreen Granpeesheh, PhD, BCBA, Founder and Executive Director of the Center for Autism and Related Disorders, Inc. (CARD) will speak at the National Autism Conference (NAC) on Friday, November 14, 2008, at the Hyatt Regency Hotel in Weston, Florida. Her presentation begins at 3:00pm.
Dr. Granpeesheh, one of the nation’s leading autism researchers and psychologists, will present, “The Child as a Whole: Why Behavioral and Biomedical Interventions are Both Critical to Growth and Recovery.”

Treatment approaches grounded in Applied Behavioral Analysis (ABA) are now considered to be at the forefront of educational interventions for children with autism. However, research supports a biomedical etiology for autism and while studies are conducted to identify exact biomedical pathways, many case studies point to successful outcome with biomedical treatments. While ABA and Biomedical practitioners have individually helped provide successful treatment models for autism, in developing a “Best Practices” Model, Dr. Granpeesheh has discovered these interventions must work together to provide the best possibilities for successful outcomes.

During the presentation, Dr. Granpeesheh will show case studies in support of the behavioral-biomedical treatment model. The recent research she will present will also show successful outcomes with these protocols.

Her presentation will be followed by an evening screening of her award-winning documentary, Recovered: Journeys Through the Autism Spectrum and Back, held in the Hyatt’s amphitheater at 8:30pm. The film tells the story of four children diagnosed with autism, who achieved success using treatments rooted in Applied Behavior Analysis. The documentary includes clips of therapy sessions along with interviews of the children who are now teenagers, their parents, therapists, and Dr. Granpeesheh.

About Dr. Doreen Granpeesheh:
Doreen Granpeesheh, PhD, BCBA is world renowned for her therapy method and recovery rates. She has treated tens of thousands of children with autism in her career and has seen significant recovery rates.

A highly recognized psychologist in the field of autism, Dr. Granpeesheh recently earned one of the Autism Society of America’s highest honors – the Wendy F. Miller National Recognition Award for Professional of the Year (2007). The award recognizes significant contributions made by a psychologist, psychiatrist, physician, and other professionals in the autism field. That same year, Dr. Granpeesheh was elected to the Autism Society of America (ASA) Board of Directors. She also serves on the Defeat Autism Now (DAN!) Executive Council and the US Autism and Aspergers Association (USAAA) Scientific Advisory Board.

“I am truly humbled and gratified to be recognized for the work that CARD does to help children and young adults with autism attain their highest potential,” Dr. Granpeesheh said. “The work we do at CARD is the epitome of a team effort, and so the credit for any recognition that comes our way must go to our hardworking and highly committed therapists, supervisors, and researchers.”

About Center for Autism and Related Disorders, Inc.:
The Center for Autism and Related Disorders, Inc. (CARD) was established in 1990 and is headquartered in Tarzana, California. CARD is among the world's largest and most experienced organizations effectively treating children with autism and related disorders, operating 17 satellite offices throughout the United States and abroad. CARD has treated thousands of children around the world. Its services include assessments, supervision, parent/teacher training and one-to-one therapy.

About Recovered: Journeys Through the Autism Spectrum and Back:
RECOVERED is a newly released documentary by filmmakers Doreen Granpeesheh, PhD, BCBA, and Michele Jaquis. The film won BEST DOCUMENTARY at the Director’s Chair Film Festival 2008, in Staten Island, New York. The documentary ends all debates on whether or not it is possible to recover from autism. This documentary offers a behind the scenes look at the lives of families with children with autism, children on the autism spectrum, and offers unprecedented insight and resources for parents navigating their way around the world of autism. “Our aim in producing this documentary is to provide hope to families of newly diagnosed children that recovery from the Autism Spectrum is indeed possible. It is also our intention to bring awareness of this fact to the general population, medical practitioners and government funding agencies so that the needed support for the treatments of Autism becomes a priority. As an artist I am interested in producing work that engages its audience on an emotional level and sometimes that means delving into difficult subject matter. It is challenging to go back and relive a part of one's life that was difficult, and Doreen and I asked these families to do that. It is my hope that the families who are featured in RECOVERED have found their involvement to be both cathartic and rewarding. “Says Michele Jaquis, Director/Producer/Videographer.


For more information about Recovered: Journeys Through the Autism Spectrum and Back, visit:
www.recoveredautism.com.